We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
74 hedge funds and large institutions have $18.6M invested in Accelerate Diagnostics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% less funds holding
Funds holding: 106 → 74 (-32)
44% less capital invested
Capital invested by funds: $33.5M → $18.6M (-$14.9M)
56% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 25
75% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 40
96% less call options, than puts
Call options by funds: $34K | Put options by funds: $842K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holders Change
-32
Holders Change %
-30.19%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
25
Closed
40
Calls
$34K
Puts
$842K
Net Calls
-$808K
Net Calls Change
-$542K
Top Buyers
| 1 |
GAM
Griffin Asset Management
New York
|
+$2.19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.03M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$870K |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$223K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$141K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.54M |
| 2 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$1.51M |
| 3 |
Axa
Paris,
France
|
-$1.32M |
| 4 |
State Street
Boston,
Massachusetts
|
-$873K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$541K |
